| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |